Amplify Weight Loss Drug & Treatment ETF
THNR$26.44 0.00 (0.00%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 31, 2025 | $0.41 | 2025-12-30 | 2025-12-30 |
| December 31, 2024 | $0.22 | 2024-12-30 | 2024-12-30 |
Dividends Summary
- Consistent Payer: Amplify Weight Loss Drug & Treatment ETF has rewarded shareholders with 2 dividend payments over the past 1 years.
- Total Returned Value: Investors who held THNR shares during this period received a total of $0.63 per share in dividend income.
- Latest Payout: The most recent dividend of $0.41/share was paid 23 days ago, on December 31, 2025.
- Yield & Schedule: THNR currently pays dividends yearly with an annual yield of 1.56%.
- Dividend Growth: Since 2024, the dividend payout has grown by 87.9%, from $0.22 to $0.41.
Company News
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
On Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
With more than 10% of the global population now suffering from obesity, the share prices of companies providing the latest weight-loss drugs have surged. However, according to industry observers, investors considering exposure through the newly launched weight-loss exchange-traded funds (ETFs) need to evaluate their potential. The Roundhill GLP...
